Autocrine activin A signalling in ovarian cancer cells regulates secretion of interleukin 6, autophagy, and cachexia
Abstract Background The majority of patients with advanced cancer develop cachexia, a weight loss syndrome that severely reduces quality of life and limits survival. Our understanding of the underlying mechanisms that cause the condition is limited, and there are currently no treatment options that...
Saved in:
Main Authors: | Kristine Pettersen (Author), Sonja Andersen (Author), Anna van derVeen (Author), Unni Nonstad (Author), Shinji Hatakeyama (Author), Christian Lambert (Author), Estelle Lach‐Trifilieff (Author), Siver Moestue (Author), Jana Kim (Author), Bjørn Henning Grønberg (Author), Alain Schilb (Author), Carsten Jacobi (Author), Geir Bjørkøy (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy
by: Xiaoling Zhong, et al.
Published: (2019) -
Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin
by: Xiaoling Zhong, et al.
Published: (2022) -
Muscle NAD+ depletion and Serpina3n as molecular determinants of murine cancer cachexia-the effects of blocking myostatin and activins
by: J.J. Hulmi, et al.
Published: (2020) -
Autocrine regulation of human sperm motility by tachykinins
by: Pinto Francisco M, et al.
Published: (2010) -
Prolactin and vitiligo: proposed autocrine/paracrine actions
by: Ghada M El-Hanafy, et al.
Published: (2021)